Skip to main content

JPMORGAN CHASE & CO

Position in AXSM — Axsome Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in AXSM

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$39,668,646
-$5,993,792 QoQ
Shares Held
162,065
-40.0% QoQ
Ownership
0.309%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 500 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 86% Shared 0% None 14%

Common Shares in AXSM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,201 across 425 Biotechnology names. AXSM ranks #39 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AXSM

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $39,668,646 162,065
2026-03-31 $45,662,438 270,160
2025-12-31 $42,590,000 233,191
2025-09-30 $30,424,801 250,513
2025-06-30 $19,596,923 187,728
2025-03-31 $14,553,438 124,783
2024-12-31 $17,082,923 201,902
2024-09-30 $19,062,323 212,110
2024-06-30 $14,858,367 184,576
2024-03-31 $15,581,826 195,261
2023-12-31 $15,114,537 189,905
2023-09-30 $12,052,947 172,456
2023-06-30 $12,448,450 173,232
2023-03-31 $10,741,941 174,156
2022-12-31 $12,925,213 167,577
2022-09-30 $7,669,195 171,878
2022-06-30 $6,729,347 175,701
2022-03-31 $7,288,199 176,086
2021-12-31 $6,620,679 175,243
2021-09-30 $872,219 26,463
2021-06-30 $1,700,867 25,213
2021-03-31 $1,333,004 23,543
2020-12-31 $1,942,325 23,841
2020-09-30 $741,997 10,414
2020-06-30 $778,697 9,464
2020-03-31 $514,174 8,740